Review paper<br>The usage of the β-adrenolytic drugs by the patients with diabetes and coexisting  diseases

Tomasz Jackowski; Jerzy Bychowski

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Abstracting and indexing Contact Instructions for authors

4/2009
vol. 4

Send email

Copy url:

abstract:

Review paper
The usage of the β-adrenolytic drugs by the patients with diabetes and coexisting diseases

Tomasz Jackowski

,

Jerzy Bychowski

Przegląd Kardiodiabetologiczny 2009; 4 (4): 161-166

Online publish date: 2010/04/21

View full text Get citation

Fifty years of experience with the β-adrenolytic drugs provided the solid evidence to recognize their high medical status and importance. But there is still debate about the variuos effects of β-adrenolytic drugs in cardiodiabetology. Diabetes is the metabolic disease that can have a negative impact on the cardiovascular system. Additionally, it can exacerbate already existing disease. The aim of this review is to explore the usage of the β-adrenolytic drugs in the cardiodiabetology.

keywords:

Review paperThe usage of the β-adrenolytic drugs by the patients with diabetes and coexisting diseases

Tomasz Jackowski , Jerzy Bychowski

β-adrenolytic drugs, cardiovascular system, diabetes

Review paper
The usage of the β-adrenolytic drugs by the patients with diabetes and coexisting diseases

Tomasz Jackowski

,

Jerzy Bychowski